Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
The Oligodendrocyte-Specific Antibody "CC1" Binds Quaking 7.
Microbiomic and Posttranslational Modifications as Preludes to Autoimmune Diseases.
Naphthoquinoxaline metabolite of mitoxantrone is less cardiotoxic than the parent compound and it can be a more cardiosafe drug in anticancer therapy.
Poster 224 Giant Cell Myocarditis Masked by Acute Inflammatory Demyelinating Polyneuropathy: A Case Report.
Inadequate outcome measures are the biggest impediment to successful clinical trials in progressive MS - Commentary.
Therapeutic Strategies and Pharmacological Tools Influencing S1P Signaling and Metabolism.
Nanocarriers as Tools in Delivering Active Compounds for Immune System Related Pathologies.
Etiological, clinical, and radiological features of longitudinally extensive myelopathy in Chinese patients.
Is size an essential criterion to define tumefactive plaque? MR features and clinical correlation in multiple sclerosis.
Guillain-Barré syndrome: What have we learnt during one century? A personal historical perspective.
Excess Body Weight during Childhood and Adolescence Is Associated with the Risk of Multiple Sclerosis: A Meta-Analysis.
Chaperome screening leads to identification of Grp94/Gp96 and FKBP4/52 as modulators of the α-synuclein-elicited immune response.
Quantitative Susceptibility Mapping and R2* Measured Changes during White Matter Lesion Development in Multiple Sclerosis: Myelin Breakdown, Myelin Debris Degradation and Removal, and Iron Accumulation.
Progressive Multiple Sclerosis.
Neutrophils and viral-induced neurologic disease.
High Intensity Aerobic and Resistance Exercise Can Improve Glucose Tolerance in Persons With Multiple Sclerosis: A Randomized Controlled Trial.
Tanshinone IIA attenuates experimental autoimmune encephalomyelitis in rats.
Assessment of the myelin water fraction in rodent spinal cord using T2-prepared ultrashort echo time MRI.
Incidence and Natural History of Idiopathic Chronic Inflammatory Demyelinating Polyneuropathy: A Population-Based Study in Iceland.
Self-induced drug intoxication in baclofen: of the calm hypotonic coma in the status epilepticus.
Autologous hematopoietic stem cell transplantation in combination with immunoablative protocol in secondary progressive multiple sclerosis--A 10-year follow-up of the first transplanted patient.
Thalamus Degeneration and Inflammation in Two Distinct Multiple Sclerosis Animal Models.
The role of primary infection of Schwann cells in the aetiology of infective inflammatory neuropathies.
Krabbe disease: One Hundred years from the bedside to the bench to the bedside.
Ongoing increase in incidence and prevalence of multiple sclerosis in Newcastle, Australia: A 50-year study.
Pages
« first
‹ previous
…
792
793
794
795
796
797
798
799
800
…
next ›
last »